Report period | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
End date of the reporting period | |||||
Capitalization, $ | |||||
Capitalization, $ | |||||
Enterprise Value | |||||
Book Value | |||||
Shareholders Book Value | |||||
Current liabilities | |||||
Noncurrent liabilities | |||||
Total liabilities | |||||
Debt | |||||
Cash and cash equivalents | |||||
Net debt | |||||
Assets | |||||
Total ordinary shares | |||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
TMCI:US | Treace Medical Concepts | Common share | - | US89455T1097 | $7.9 |
Company name | Treace Medical Concepts |
---|---|
Tags | #medical equipment |
Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment |
Business address | 203 Fort Wade Road Suite 150 Ponte Vedra, FL 32081 United States |
Mailing address | 203 Fort Wade Road Suite 150 Ponte Vedra, FL 32081 United States |
Website | investors.treace.com |
Information disclosure | www.sec.gov |